Cadrenal Therapeutics Inc...

NASDAQ: CVKD · Real-Time Price · USD
14.68
-0.81 (-5.23%)
At close: Jun 05, 2025, 3:59 PM
15.18
3.41%
After-hours: Jun 05, 2025, 07:16 PM EDT

Cadrenal Therapeutics Common Stock Revenue

Cadrenal Therapeutics Common Stock reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, Cadrenal Therapeutics Common Stock generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
4
Market Cap
28.87M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.